Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral indomethacin for the prevention of post-ERCP pancreatitis
TCTR20190218006Phase 4Recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Gastroenterological Association of Thailand. Started Feb 2019; status: recruiting.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on TCTR20190218006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190218006.